世界の進行性多巣性白質脳症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Progressive Multifocal Leukoencephalopathy Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4817
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、進行性多巣性白質脳症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗レトロウイルス療法、抗ウイルス/抗JCV、その他）、用途別市場規模（病院薬局、ドラッグストア、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・進行性多巣性白質脳症治療の市場動向
・企業の競争状況、市場シェア
・進行性多巣性白質脳症治療の種類別市場規模（抗レトロウイルス療法、抗ウイルス/抗JCV、その他）
・進行性多巣性白質脳症治療の用途別市場規模（病院薬局、ドラッグストア、小売薬局）
・進行性多巣性白質脳症治療の北米市場規模2016-2027（アメリカ、カナダ）
・進行性多巣性白質脳症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・進行性多巣性白質脳症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・進行性多巣性白質脳症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・進行性多巣性白質脳症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Roche、Gilead Sciences、GlaxoSmithKline、Sanofi、Allergan、Novartis、Mylan、AbbVie、Bristol-Myers Squibb）
・結論

Progressive multifocal leukoencephalopathy is a rare but debilitating and frequently fatal viral disease of the central nervous system, primarily affecting individuals with chronically and severely suppressed immune systems.
Growing prevalence of HIV is expected to drive the growth of the progressive multifocal leukoencephalopathy treatment market.

Market Analysis and Insights: Global Progressive Multifocal Leukoencephalopathy Treatment Market
The global Progressive Multifocal Leukoencephalopathy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Progressive Multifocal Leukoencephalopathy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Progressive Multifocal Leukoencephalopathy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Progressive Multifocal Leukoencephalopathy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Progressive Multifocal Leukoencephalopathy Treatment market.

Global Progressive Multifocal Leukoencephalopathy Treatment Scope and Market Size
Progressive Multifocal Leukoencephalopathy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Progressive Multifocal Leukoencephalopathy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-Retroviral Therapy
Antiviral/Anti JCV
Other Symptomatic

Segment by Application
Hospital Pharmacies
Drug Stores
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Roche
Gilead Sciences
GlaxoSmithKline
Sanofi
Allergan
Novartis
Mylan
AbbVie

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-Retroviral Therapy
1.2.3 Antiviral/Anti JCV
1.2.4 Other Symptomatic
1.3 Market by Application
1.3.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Perspective (2016-2027)
2.2 Progressive Multifocal Leukoencephalopathy Treatment Growth Trends by Regions
2.2.1 Progressive Multifocal Leukoencephalopathy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Progressive Multifocal Leukoencephalopathy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Progressive Multifocal Leukoencephalopathy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Progressive Multifocal Leukoencephalopathy Treatment Industry Dynamic
2.3.1 Progressive Multifocal Leukoencephalopathy Treatment Market Trends
2.3.2 Progressive Multifocal Leukoencephalopathy Treatment Market Drivers
2.3.3 Progressive Multifocal Leukoencephalopathy Treatment Market Challenges
2.3.4 Progressive Multifocal Leukoencephalopathy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Progressive Multifocal Leukoencephalopathy Treatment Players by Revenue
3.1.1 Global Top Progressive Multifocal Leukoencephalopathy Treatment Players by Revenue (2016-2021)
3.1.2 Global Progressive Multifocal Leukoencephalopathy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Progressive Multifocal Leukoencephalopathy Treatment Revenue
3.4 Global Progressive Multifocal Leukoencephalopathy Treatment Market Concentration Ratio
3.4.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Progressive Multifocal Leukoencephalopathy Treatment Revenue in 2020
3.5 Progressive Multifocal Leukoencephalopathy Treatment Key Players Head office and Area Served
3.6 Key Players Progressive Multifocal Leukoencephalopathy Treatment Product Solution and Service
3.7 Date of Enter into Progressive Multifocal Leukoencephalopathy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Progressive Multifocal Leukoencephalopathy Treatment Breakdown Data by Type
4.1 Global Progressive Multifocal Leukoencephalopathy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Progressive Multifocal Leukoencephalopathy Treatment Forecasted Market Size by Type (2022-2027)

5 Progressive Multifocal Leukoencephalopathy Treatment Breakdown Data by Application
5.1 Global Progressive Multifocal Leukoencephalopathy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Progressive Multifocal Leukoencephalopathy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size (2016-2027)
6.2 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
6.2.1 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2021)
6.2.2 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2022-2027)
6.2.3 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2027)
6.3 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application
6.3.1 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2021)
6.3.2 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2022-2027)
6.3.3 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2027)
6.4 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country
6.4.1 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2016-2021)
6.4.2 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size (2016-2027)
7.2 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
7.2.1 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2027)
7.3 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application
7.3.1 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2027)
7.4 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country
7.4.1 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
8.2.1 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application
8.3.1 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Region
8.4.1 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size (2016-2027)
9.2 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
9.2.1 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2027)
9.3 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application
9.3.1 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2027)
9.4 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country
9.4.1 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
10.2.1 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application
10.3.1 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country
10.4.1 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Progressive Multifocal Leukoencephalopathy Treatment Introduction
11.1.4 Pfizer Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Progressive Multifocal Leukoencephalopathy Treatment Introduction
11.2.4 Roche Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Progressive Multifocal Leukoencephalopathy Treatment Introduction
11.3.4 Gilead Sciences Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
11.3.5 Gilead Sciences Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Progressive Multifocal Leukoencephalopathy Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Progressive Multifocal Leukoencephalopathy Treatment Introduction
11.5.4 Sanofi Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Progressive Multifocal Leukoencephalopathy Treatment Introduction
11.6.4 Allergan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
11.6.5 Allergan Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Progressive Multifocal Leukoencephalopathy Treatment Introduction
11.7.4 Novartis Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Progressive Multifocal Leukoencephalopathy Treatment Introduction
11.8.4 Mylan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Progressive Multifocal Leukoencephalopathy Treatment Introduction
11.9.4 AbbVie Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
11.9.5 AbbVie Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Progressive Multifocal Leukoencephalopathy Treatment Introduction
11.10.4 Bristol-Myers Squibb Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
11.10.5 Bristol-Myers Squibb Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-Retroviral Therapy
Table 3. Key Players of Antiviral/Anti JCV
Table 4. Key Players of Other Symptomatic
Table 5. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions (2016-2021)
Table 9. Global Progressive Multifocal Leukoencephalopathy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions (2022-2027)
Table 11. Progressive Multifocal Leukoencephalopathy Treatment Market Trends
Table 12. Progressive Multifocal Leukoencephalopathy Treatment Market Drivers
Table 13. Progressive Multifocal Leukoencephalopathy Treatment Market Challenges
Table 14. Progressive Multifocal Leukoencephalopathy Treatment Market Restraints
Table 15. Global Progressive Multifocal Leukoencephalopathy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Players (2016-2021)
Table 17. Global Top Progressive Multifocal Leukoencephalopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progressive Multifocal Leukoencephalopathy Treatment as of 2020)
Table 18. Ranking of Global Top Progressive Multifocal Leukoencephalopathy Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Progressive Multifocal Leukoencephalopathy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Progressive Multifocal Leukoencephalopathy Treatment Product Solution and Service
Table 22. Date of Enter into Progressive Multifocal Leukoencephalopathy Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Progressive Multifocal Leukoencephalopathy Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Progressive Multifocal Leukoencephalopathy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Progressive Multifocal Leukoencephalopathy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Progressive Multifocal Leukoencephalopathy Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Progressive Multifocal Leukoencephalopathy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Progressive Multifocal Leukoencephalopathy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Progressive Multifocal Leukoencephalopathy Treatment Product
Table 65. Pfizer Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Progressive Multifocal Leukoencephalopathy Treatment Product
Table 70. Roche Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Gilead Sciences Company Details
Table 73. Gilead Sciences Business Overview
Table 74. Gilead Sciences Progressive Multifocal Leukoencephalopathy Treatment Product
Table 75. Gilead Sciences Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021) & (US$ Million)
Table 76. Gilead Sciences Recent Development
Table 77. GlaxoSmithKline Company Details
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Progressive Multifocal Leukoencephalopathy Treatment Product
Table 80. GlaxoSmithKline Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021) & (US$ Million)
Table 81. GlaxoSmithKline Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Progressive Multifocal Leukoencephalopathy Treatment Product
Table 85. Sanofi Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Allergan Company Details
Table 88. Allergan Business Overview
Table 89. Allergan Progressive Multifocal Leukoencephalopathy Treatment Product
Table 90. Allergan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021) & (US$ Million)
Table 91. Allergan Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Progressive Multifocal Leukoencephalopathy Treatment Product
Table 95. Novartis Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Mylan Company Details
Table 98. Mylan Business Overview
Table 99. Mylan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021) & (US$ Million)
Table 100. Mylan Recent Development
Table 101. AbbVie Company Details
Table 102. AbbVie Business Overview
Table 103. AbbVie Progressive Multifocal Leukoencephalopathy Treatment Product
Table 104. AbbVie Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021) & (US$ Million)
Table 105. AbbVie Recent Development
Table 106. Bristol-Myers Squibb Company Details
Table 107. Bristol-Myers Squibb Business Overview
Table 108. Bristol-Myers Squibb Progressive Multifocal Leukoencephalopathy Treatment Product
Table 109. Bristol-Myers Squibb Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021) & (US$ Million)
Table 110. Bristol-Myers Squibb Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type: 2020 VS 2027
Figure 2. Anti-Retroviral Therapy Features
Figure 3. Antiviral/Anti JCV Features
Figure 4. Other Symptomatic Features
Figure 5. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Progressive Multifocal Leukoencephalopathy Treatment Report Years Considered
Figure 10. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions (2022-2027)
Figure 14. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Players in 2020
Figure 15. Global Top Progressive Multifocal Leukoencephalopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progressive Multifocal Leukoencephalopathy Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Progressive Multifocal Leukoencephalopathy Treatment Revenue in 2020
Figure 17. Global Progressive Multifocal Leukoencephalopathy Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Progressive Multifocal Leukoencephalopathy Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2016-2027)
Figure 21. North America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2016-2027)
Figure 22. North America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Country (2016-2027)
Figure 23. United States Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2016-2027)
Figure 27. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2016-2027)
Figure 28. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Share by Country (2016-2027)
Figure 29. Germany Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Share by Region (2016-2027)
Figure 39. China Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
Figure 60. Gilead Sciences Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
Figure 63. Allergan Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Global Progressive Relapsing Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4818 2021年4月 99Pages
QYResearch社発行の本調査資料では、進行性再発性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）、用途別市場規模（診療所、病院、その他）、主要...

世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Primary Progressive Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4790 2021年4月 94Pages
QYResearch社発行の本調査資料では、一次進行性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、ラキニモドナトリウム、その他）、用途別市場規模（病院、診療所、...

世界の進行性運動失調及び脱力障害症候群治療市場規模・現状・予測（2021年-2027年）

Global Treatment for Syndromes of Progressive Ataxia and Weakness Disorders Market Size, Status and Forecast 2021-2027
QYR2104Z5740 2021年4月 98Pages
QYResearch社発行の本調査資料では、進行性運動失調及び脱力障害症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、小分子技術）、用途別市場規模（フリードライヒ運動失調症、遺伝性ニューロパチー、マチャドジョセフ病...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

Global Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4085 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界の進行性再発性多発性硬化症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Progressive Relapsing Multiple Sclerosis Treatment Market The global Progressive Relapsing Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standar…
世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Primary Progressive Multiple Sclerosis Treatment Market The global Primary Progressive Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…
世界の集中アンチエイジングトリートメント市場規模・現状・予測（2021年-2027年） The topical treatment is the most popular and prescribed method for anti-aging treatment. Various types of creams for the topical treatment are available in the market. The intensive anti-aging treatment market is expected to show exponential growth over the forecast period due to continuous rise in…
世界の進行性運動失調及び脱力障害症候群治療市場規模・現状・予測（2021年-2027年） Ataxia refers to a disorder caused by the lack of coordination of muscle movements that impairs the ability to smoothly perform coordinated voluntary activities. Factors causing the disorder include cerebral and cerebellar disorders, peripheral nerve disorders, thalamic disorders, injuries to poster…
世界のインテンシブアンチエイジングトリートメント市場 2021：企業別、地域別、種類・用途別 The Intensive Anti-Aging Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …